NewslettersProstate Cell News Inhibition of the Cyclin K-CDK12 Complex Induces DNA Damage and Increases the Effect of Androgen Deprivation Therapy in Prostate Cancer By Bob - November 3, 2023 0 Scientists investigated the suitability of the Cyclin K-CDK12 complex as a novel therapeutic approach in prostate cancer using the new covalent CDK12/13 inhibitor THZ531. [International Journal of Cancer] Full ArticleGraphical Abstract